Backed by preclinical data and funding from The Michael J. Fox Foundation, Ariadne Bio is advancing AB-300, a serotonin 2A receptor agonist, as a potential treatment for Parkinson’s-related apathy. The post Palomar Labs Spins Out Ariadne Bio to Advance Non-Hallucinogenic Therapy for Parkinson’s Apathy appeared first on GEN - Genetic Engineering and Biotechnology News .
A Florida family is suing a fertility clinic they said it swapped out the wrong sperm during an IVF procedure. Cristian Benavides spoke to the family about their ordeal.
Any doubts about China’s ambitions to be a major global competitor in biopharma are rapidly disappearing. On Friday, the Chinese government issued the latest five-year plan for its biotech and pharma…
A jump in the prices of narcotic substances due to the prolonged ethnic conflict is believed to be the primary reason behind the shift to addiction-causing pharmaceutical drugs
A jump in the prices of narcotic substances due to the prolonged ethnic conflict is believed to be the primary reason behind the shift to addiction-causing pharmaceutical drugs
